This topic contains a solution. Click here to go to the answer

Author Question: Most scholars consider which institution within the European Union to be the weakest? a. The ... (Read 101 times)

Cooldude101

  • Hero Member
  • *****
  • Posts: 557
Most scholars consider which institution within the European Union to be the weakest?
 
  a. The Commission
  b. The Council of Ministers
  c. The European Court of Justice
  d. The Parliament
  e. The Security Council

Question 2

The European Court of Justice decides
 
  a. cases in which all parties are voluntary participants.
  b. lawsuits by individuals and corporations against the European Union.
  c. only cases that have been considered by the European Union or the Commission.
  d. cases where national laws are ambiguous or in conflict.
  e. when member states' national regulations take precedence over EU regulations.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Joy Chen

  • Sr. Member
  • ****
  • Posts: 354
Answer to Question 1

d

Answer to Question 2

b




Joy Chen

  • Sr. Member
  • ****
  • Posts: 354

 

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

Fewer than 10% of babies are born on their exact due dates, 50% are born within 1 week of the due date, and 90% are born within 2 weeks of the date.

Did you know?

Oxytocin is recommended only for pregnancies that have a medical reason for inducing labor (such as eclampsia) and is not recommended for elective procedures or for making the birthing process more convenient.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library